Back to Search
ROBERT ROBEY, MD
MD
Nephrology Physician
NPI: 1861578114IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
036-093090(IL)
Nephrology PhysicianPrimary
Internal Medicine — Nephrology
Code: 207RN0300X
036-093090(IL)
Hypertension Specialist Physician
Internal Medicine — Hypertension Specialist
Code: 207RH0005X
036-093090(IL)
CMS Specialties
PrimaryNEPHROLOGY
Education
OTHER
Class of 1985
Research & Publications (20)
Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis.
PMID 19130886·Semin Cancer Biol·2009
6-review
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt.
PMID 16892082·Oncogene·2006
6-review
A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine.
PMID 19417029·Clin Cancer Res·2009
3-trial
Identification of compounds that correlate with ABCG2 transporter function in the National Cancer Institute Anticancer Drug Screen.
PMID 19633067·Mol Pharmacol·2009
4-observational
mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition.
PMID 19620286·Mol Cell Biol·2009
7-preclinical
Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats.
PMID 19406679·Growth Horm IGF Res·2009
7-preclinical
Does furosemide have a role in the management of hypercalcemia?
PMID 19153420·Ann Intern Med·2009
8-other
The CD8 and CD4 T-cell response against Kaposi's sarcoma-associated herpesvirus is skewed towards early and late lytic antigens.
PMID 19536280·PLoS One·2009
8-other
Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells.
PMID 19132374·Cancer Chemother Pharmacol·2009
8-other
Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478.
PMID 19059384·Biochem Pharmacol·2009
8-other
ABCG2 is expressed in late spermatogenesis and is associated with the acrosome.
PMID 19032939·Biochem Biophys Res Commun·2009
7-preclinical
Arginine 383 is a crucial residue in ABCG2 biogenesis.
PMID 19406100·Biochim Biophys Acta·2009
7-preclinical
The 315-316 deletion determines the BXP-21 antibody epitope but has no effect on the function of wild type ABCG2 or the Q141K variant.
PMID 19002564·Mol Cell Biochem·2009
8-other
Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2.
PMID 18971320·Drug Metab Dispos·2009
8-other
The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance.
PMID 19148526·Oncol Rep·2009
8-other
Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus.
PMID 18996347·Cell Host Microbe·2008
7-preclinical
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
PMID 18829547·Cancer Res·2008
7-preclinical
Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.
PMID 18710444·BJU Int·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- WRJVAMC R&D SVC (151), 215 N MAIN ST
WHITE RIVER JCT, VT 05009 - Phone
- (802) 295-9363
Quick Facts
- NPI
- 1861578114
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile